Delivery Order SPE2DB22D2206-SPE2DB24FGB62
Award Date 3/14/24
Potential Completion Date 3/15/24
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,687.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VISIPAQUE 320 MG/ML INFUS BTL 150ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) provides for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $8,387.55, is a Delivery Order contract with a firm fixed price. It has an ultimate completion date of November 14, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for...
- This federal contract award, valued at $1,650.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a specialty pharmaceutical product, with a ceiling value of $4,219.10 and a performance period through April 2, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract is for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a ceiling value of $1,599.88. The contract type is a Delivery Order with a Firm Fixed Price pricing model. The ultimate completion date is July 16, 2025. This contract is not set aside and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,668.90 firm fixed-price delivery order is for VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product, with a ceiling value of $1,650.56. It is a firm fixed price delivery order contract, with a period of performance ending on June 18, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product, to support the Department of Defense (DoD) and other government agencies. The contract has a firm fixed price of $1,265.73 and a completion date of May 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Visipaque 320 mg/ml, a pharmaceutical product, with a ceiling value of $26,715.17 and a period of performance through July 3, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award, valued at $2,089.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML medical supplies. The contract has a period of performance through January 18, 2024 and is structured as a firm fixed-price delivery order. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains...